Same Indication

Insulin Glargine vs Trastuzumab

Insulin Glargine vs Trastuzumab: Overview

This comparison examines the pharmacological differences between Insulin Glargine and Trastuzumab.

Mechanism of Action

Insulin Glargine: Long-acting insulin analogue that binds insulin receptors.

Trastuzumab: Anti-HER2 monoclonal antibody inhibiting receptor signaling.

Pharmacokinetics

Half-life: Insulin Glargine β€” 12-24 hours; Trastuzumab β€” 28 days.

Chemical Properties

Type: Insulin Glargine β€” Protein; Trastuzumab β€” Antibody.